$EXAS
EXACT SCIENCES CORP

2012 Q2 Form 10-Q Financial Statement

#000110465912033204 Filed on May 04, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2012 Q1 2011 Q1
Revenue $1.036M $1.036M $1.040M
YoY Change -0.58% -0.38% -20.0%
Cost Of Revenue $0.00 $0.00 $6.000K
YoY Change -100.0% -100.0%
Gross Profit $1.036M $1.036M $1.034M
YoY Change 0.0% 0.19% -20.46%
Gross Profit Margin 100.0% 100.0% 99.42%
Selling, General & Admin $3.724M $2.739M $2.447M
YoY Change 50.1% 11.93% 52.94%
% of Gross Profit 359.46% 264.38% 236.65%
Research & Development $12.20M $8.999M $2.989M
YoY Change 134.79% 201.07% 66.06%
% of Gross Profit 1177.8% 868.63% 289.07%
Depreciation & Amortization $200.0K $202.0K $67.00K
YoY Change 201.49%
% of Gross Profit 19.31% 19.5% 6.48%
Operating Expenses $15.93M $11.74M $5.436M
YoY Change 107.42% 115.93% 59.88%
Operating Profit -$14.89M -$10.70M -$4.402M
YoY Change 124.18% 143.12% 109.62%
Interest Expense $5.000K $5.000K $5.000K
YoY Change 0.0% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$14.80M -$10.60M -$4.400M
YoY Change 124.24% 140.91% 109.52%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$14.80M -$10.60M -$4.400M
YoY Change 124.24% 140.91% 109.52%
Net Earnings / Revenue -1428.57% -1023.17% -423.08%
Basic Earnings Per Share
Diluted Earnings Per Share -$259.6K -$186.9K -$84.78K
COMMON SHARES
Basic Shares Outstanding 57.14M shares 57.02M shares 51.93M shares
Diluted Shares Outstanding 51.93M shares

Balance Sheet

Concept 2012 Q2 2012 Q1 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.90M $83.50M $89.70M
YoY Change -15.09% -6.91% 300.45%
Cash & Equivalents $6.026M $12.29M $72.07M
Short-Term Investments $64.80M $71.20M $17.70M
Other Short-Term Assets $2.300M $1.900M $500.0K
YoY Change 283.33% 280.0% -54.55%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $73.21M $85.45M $90.20M
YoY Change -12.95% -5.26% 283.83%
LONG-TERM ASSETS
Property, Plant & Equipment $2.870M $2.551M $1.000M
YoY Change 105.0% 155.1% 66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.870M $2.551M $1.000M
YoY Change 105.0% 155.1% 66.67%
TOTAL ASSETS
Total Short-Term Assets $73.21M $85.45M $90.20M
Total Long-Term Assets $2.870M $2.551M $1.000M
Total Assets $76.08M $88.01M $91.20M
YoY Change -11.02% -3.5% 278.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $800.0K $900.0K $800.0K
YoY Change -27.27% 12.5% 166.67%
Accrued Expenses $3.700M $2.600M $1.400M
YoY Change 105.56% 85.71% 16.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.639M $7.692M $6.400M
YoY Change 21.68% 20.19% -13.51%
LONG-TERM LIABILITIES
Long-Term Debt $1.000M $1.000M $1.000M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $2.400M $3.500M $7.600M
YoY Change -63.08% -53.95% -30.28%
Total Long-Term Liabilities $3.400M $4.500M $8.600M
YoY Change -54.67% -47.67% -27.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.639M $7.692M $6.400M
Total Long-Term Liabilities $3.400M $4.500M $8.600M
Total Liabilities $12.10M $12.10M $15.00M
YoY Change -17.12% -19.33% -22.68%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $64.02M $75.86M $76.30M
YoY Change
Total Liabilities & Shareholders Equity $76.08M $88.01M $91.20M
YoY Change -11.02% -3.5% 278.42%

Cashflow Statement

Concept 2012 Q2 2012 Q1 2011 Q1
OPERATING ACTIVITIES
Net Income -$14.80M -$10.60M -$4.400M
YoY Change 124.24% 140.91% 109.52%
Depreciation, Depletion And Amortization $200.0K $202.0K $67.00K
YoY Change 201.49%
Cash From Operating Activities -$12.30M -$11.20M -$5.500M
YoY Change 108.47% 103.64% 89.66%
INVESTING ACTIVITIES
Capital Expenditures -$500.0K $195.0K $245.0K
YoY Change 0.0% -20.41% -222.5%
Acquisitions
YoY Change
Other Investing Activities $6.300M -$13.70M -$1.000M
YoY Change -122.83% 1270.0% -44.44%
Cash From Investing Activities $5.800M -$13.90M -$1.200M
YoY Change -120.64% 1058.33% -40.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 300.0K 1.600M 0.000
YoY Change 50.0% -100.0%
NET CHANGE
Cash From Operating Activities -12.30M -11.20M -5.500M
Cash From Investing Activities 5.800M -13.90M -1.200M
Cash From Financing Activities 300.0K 1.600M 0.000
Net Change In Cash -6.200M -23.50M -6.700M
YoY Change -81.66% 250.75% 76.32%
FREE CASH FLOW
Cash From Operating Activities -$12.30M -$11.20M -$5.500M
Capital Expenditures -$500.0K $195.0K $245.0K
Free Cash Flow -$11.80M -$11.40M -$5.745M
YoY Change 118.52% 98.35% 112.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-6679000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14000 USD
CY2011Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
14000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1240000 USD
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
245000 USD
CY2011Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1498000 USD
CY2011Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2493000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5453000 USD
CY2011Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5000 USD
CY2011Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-399000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-208000 USD
CY2011Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
222000 USD
CY2011Q1 exas Warrant Licensing Expense
WarrantLicensingExpense
27000 USD
CY2011Q1 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
-1036000 USD
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
686000 USD
CY2011Q1 us-gaap Depreciation
Depreciation
67000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-23489000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1642000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13824000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11307000 USD
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56624763 shares
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
83495000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-221824000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
304767000 USD
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10645000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10702000 USD
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
11738000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
1036000 USD
CY2012Q1 us-gaap Revenues
Revenues
1036000 USD
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51930000 shares
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51930000 shares
CY2011Q1 us-gaap Deferred Compensation Arrangement With Individual Employer Contribution
DeferredCompensationArrangementWithIndividualEmployerContribution
169000 USD
CY2011Q1 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-2000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72073000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78752000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
566000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4439000 USD
CY2011Q4 exas Interest Payable Noncurrent
InterestPayableNoncurrent
42000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1000000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7977000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4143000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3069000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
765000 USD
CY2011Q4 us-gaap Assets
Assets
96953000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2558000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
796000 USD
CY2011Q4 exas Office And Computer Equipment Gross
OfficeAndComputerEquipmentGross
729000 USD
CY2011Q4 exas Laboratory Equipment Gross
LaboratoryEquipmentGross
2314000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3354000 USD
CY2011Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
23000 USD
CY2011Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
288000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
94395000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1034000 USD
CY2011Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
57580000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88005000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
75863000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7692000 USD
CY2012Q1 us-gaap Assets
Assets
88005000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2551000 USD
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3549000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
85454000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35781000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
96953000 USD
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57109496 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56624763 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57109496 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
EXACT SCIENCES CORP
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001124140
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
57141155 shares
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2011Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4371000 USD

Files In Submission

Name View Source Status
0001104659-12-033204-index-headers.html Edgar Link pending
0001104659-12-033204-index.html Edgar Link pending
0001104659-12-033204.txt Edgar Link pending
0001104659-12-033204-xbrl.zip Edgar Link pending
a12-7211_110q.htm Edgar Link pending
a12-7211_1ex10d1.htm Edgar Link pending
a12-7211_1ex31d1.htm Edgar Link pending
a12-7211_1ex31d2.htm Edgar Link pending
a12-7211_1ex32d1.htm Edgar Link pending
exas-20120331.xml Edgar Link completed
exas-20120331.xsd Edgar Link pending
exas-20120331_cal.xml Edgar Link unprocessable
exas-20120331_def.xml Edgar Link unprocessable
exas-20120331_lab.xml Edgar Link unprocessable
exas-20120331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending